1. Home
  2. PLAG vs BOLD Comparison

PLAG vs BOLD Comparison

Compare PLAG & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Planet Green Holdings Corp.

PLAG

Planet Green Holdings Corp.

HOLD

Current Price

$2.24

Market Cap

23.5M

ML Signal

HOLD

Logo Boundless Bio Inc. Common Stock

BOLD

Boundless Bio Inc. Common Stock

HOLD

Current Price

$1.14

Market Cap

26.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAG
BOLD
Founded
1986
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
23.5M
26.2M
IPO Year
N/A
2024

Fundamental Metrics

Financial Performance
Metric
PLAG
BOLD
Price
$2.24
$1.14
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$4.00
AVG Volume (30 Days)
297.9K
172.6K
Earning Date
11-14-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,494,847.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$1.00
52 Week High
$3.28
$3.54

Technical Indicators

Market Signals
Indicator
PLAG
BOLD
Relative Strength Index (RSI) 51.00 44.40
Support Level $1.96 $1.00
Resistance Level $2.77 $1.18
Average True Range (ATR) 0.59 0.07
MACD -0.01 0.00
Stochastic Oscillator 47.74 58.24

Price Performance

Historical Comparison
PLAG
BOLD

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

Share on Social Networks: